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Mycobacterium abscessus, a member of the group of 
non-tuberculous mycobacteria, has been identified as an 
emerging pulmonary pathogen in humans. However, little is 
known about the protective immune response of antigen- 
presenting cells, such as dendritic cells (DCs), which guard 
against M. abscessus infection. The M. abscessus gene 
MAB1843 encodes D-alanyl-D-alanine dipeptidase, which 
catalyzes the hydrolysis of D-alanyl-D-alanine dipeptide. We 
investigated whether MAB1843 is able to interact with DCs to 
enhance the effectiveness of the host’s immune response. 
MAB1843 was found to induce DC maturation via toll-like 
receptor 4 and its downstream signaling pathways, such as the 
mitogen-activated protein kinase and nuclear factor kappa B 
pathways. In addition, MAB1843-treated DCs stimulated the 
proliferation of T cells and promoted Th1 polarization. Our 
results indicate that MAB1843 could potentially regulate the 
immune response to M. abscessus, making it important in the 
development of an effective vaccine against this mycobacterium. 
[BMB Reports 2016; 49(10): 554-559]
INTRODUCTION
Mycobacterium abscessus is the most well known rapidly 
growing mycobacterium (RGM), existing in natural habitats 
such as soil and water (1, 2) and usually found in intracellular 
compartments within an infected host. Infection by this 
mycobacterium can occur in various parts of the host’s body, 
regardless of their immunity. Approximately 80% of 
pulmonary RGM infections in the USA are attributed to M. 
abscessus (3). Unfortunately, the resistance of this species to 
antituberculosis drugs and antibiotics has become a major 
obstacle to its treatment in infected patients (4-6).
Recent studies have revealed that antigen-presenting cell 
(APC)-mediated innate and adaptive immunities play a pivotal 
role in combating M. abscessus infection (7-9). These studies 
also pointed out the importance of research on the 
pathogenicity of M. abscessus and relevant immunotherapies. 
In the M. abscessus-infected mouse model, the interferon- 
gamma (IFN-) and tumor necrosis factor alpha (TNF-) 
secreted by various immune cells play a key role as regulators 
of the bacterial infection (10, 11). Furthermore, M. abscessus 
induces dendritic cell (DC) and macrophage secretion of 
TNF-, interleukin-6 (IL-6), and IL-12p70 via the toll-like 
receptor 2 (TLR2) and TLR4 pathways (7, 8).
DCs are well known as the most powerful APCs. In 
peripheral tissues, immature DCs express low levels of 
costimulatory and major histocompatibility complex (MHC) 
molecules and exhibit a high level of endocytosis (12, 13). 
When DCs recognize pathogens via pattern recognition 
receptors, they start maturing, and in the process express high 
levels of costimulatory and MHC molecules, and pro-
inflammatory cytokines, and their endocytosis capacity is 
downregulated. In addition, DC maturation occurs as the cells 
migrate towards the lymph nodes where they present antigens 
to naïve T cells, which induces T cell activation and 
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Fig. 1. Purification and cytotoxicity of recombinant MAB1843. (A) 
Recombinant MAB1843 was purified by affinity chromatography 
with Ni-NTA resin and then subjected to SDS-PAGE and staining 
with Coomassie Brilliant Blue (left panel), as well as analysis by 
western blotting using 1:1000 mouse anti-His tag antibodies (right 
panel). (B) Dendritic cells were treated with the indicated 
concentrations of MAB1843 and LPS for 24 h and then stained 
with Annexin V/PI. The results are representative of three 
independent experiments. (C) Endotoxin levels in the purified 
MAB1843 were analyzed by the LAL endotoxin assay kit.
Fig. 2. MAB1843 induces the maturation of dendritic cells (DCs). 
(A) Immature DCs were cultured with 0.5 or 1 g/ml of 
MAB1843 or 50 ng/ml of LPS for 24 h and analyzed for the 
expression of surface markers by two-color flow cytometry. DCs 
were stained with FITC anti-CD11c antibodies and PE anti-CD80 
antibodies, PE anti-CD86 antibodies, PE anti-MHC class I antibodies,
or PE anti-MHC class II antibodies. (B and C) Immature DCs were 
cultured with 0.5 or 1 g/ml of MAB1843 or 50 ng/ml of LPS for 
24 h. The amounts of TNF-, IL-1, IL-6, IL-12p70, and IL-10 in 
the culture medium were measured by ELISA. The experiments 
were run at least in triplicates. *P ＜ 0.05, **P ＜ 0.01, and 
***P ＜ 0.001, when compared with DCs treated with MAB1843 
only. (D) Mature DCs were generated by stimulating the immature 
cells with 50 ng/ml of LPS or 0.5 or 1 g/ml of MAB1843 for 24 
h. Endocytic activity at 37oC and at 4oC was assessed by flow 
cytometry, based on dextran-FITC uptake. The percentages of 
dextran-FITC＋ CD11c＋ cells are indicated. The results are 
representative of three independent experiments.
proliferation. In this way, DCs act as the link between innate 
immunity and adaptive immunity, and hence, they have gained 
much attention in cancer immunotherapy research (12-15).
Mycobacterial proteins, such as PE-RGRS, LprA, MAB2560, 
Rv0652, Rv0462, MAP1305, HspX, and HBHA, have been 
shown to induce DC maturation and T cell activation (8, 
16-22). These proteins activate TLR2 or TLR4 signaling and 
can be used as adjuvants for DC maturation. We recently 
suggested MAB2560 as the first ligand isolated from M. 
abscessus that induces the activation of DCs via TLR4; 
however, little is known about how M. abscessus-derived 
ligands affect the immune system.
MAB1843, a 222-amino-acid D-alanyl-D-alanine dipeptidase 
(D-Ala-D-Ala dipeptidase; EC number: 3.4.13.22), is a 
hypothetical antigen of M. abscessus. However, the function 
of MAB1843 in M. abscessus and the manner in which it 
affects the immune system remain unknown.
In this study, we aimed to elucidate the effects of MAB1843 
on the immune system, with a focus on the maturation of DCs 
as well as their endocytosis and cytokine-producing abilities. 
In particular, we examined whether MAB1843 affects DC 
maturation through TLRs and how the activated DCs affect T 
cells. Knowledge on these mechanisms could contribute to the 
development of vaccines against M. abscessus.
RESULTS
MAB1843 induces dendritic cell maturation
First, we inspected the purity and toxicity of the recombinant 
MAB1843 before testing its physiological effect on DCs. The 
purity of MAB1843 was confirmed by Coomassie Brilliant 
Blue staining and western blot analysis using anti-His antibody 
(Ab). The apparent molecular size of the purified protein was 
approximately 24 kDa (Fig. 1A). In addition, the toxicity of 
MAB1843 on DCs was tested using Annexin V/propidium 
iodide (PI) staining and analyzed by fluorescence-activated cell 
sorting. Compared with the effect of a high dose of 
lipopolysaccharide (LPS; 1,000 ng/ml) as a positive control, 
MAB1843 was not cytotoxic to DCs (Fig. 1B). To exclude the 
effects of endotoxin contamination, we also checked for 
endotoxins in the purified MAB1843. Using the limulus 
amebocyte lysate (LAL) endotoxin assay kit (Lonza, Basel, 
Switzerland), we found the endotoxin levels in the purified 
MAB1843 to be ＜ 0.1 EU/ml (Fig. 1C), indicating that certain 
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Fig. 3. MAB1843 induces TLR4 signaling during dendritic cell (DC)
maturation. (A) DCs derived from wild type (WT), TLR2 knockout 
(KO), and TLR4 KO mice were treated with MAB1843 (1 g/ml), 
LPS (50 ng/ml), Pam3CSK4 (Pam3) (10 g/ml), imiquimod (Imiq) 
(1 g/ml), ODN1826 (ODN) (1 g/ml), or Poly I:C (10 g/ml) for 
24 h. The production of TNF- and IL-6 in DCs was measured by 
ELISA. The experiments were run at least in triplicates. ***P ＜
0.001. (B) DCs were treated with MAB1843 (1 g/ml) or LPS (50 
ng/ml) for 0, 5, 15, 30, and 60 min. Anti-p-p38 antibody, anti- 
p-ERK antibody, anti-p-JNK antibody, anti-p38 antibody, anti-ERK 
antibody, anti-JNK antibody, anti-IB antibody, and anti--actin 
antibody was added to the western blot membrane. The results 
are representative of three independent experiments.
Fig. 4. MAB1843 induces T cell proliferation and Th1 polarization. (A 
and B) Transgenic OVA-specific CD8＋ T cells and transgenic OVA- 
specific CD4＋ T cells were isolated from OT-I and OT-II mice, 
respectively. T cells were stained with carboxyfluorescein succinimidyl 
ester and co-cultured for 96 h with DCs treated with 1 g/ml of 
MAB1843 or 50 ng/ml of LPS. The cells were then analyzed by flow 
cytometry. (C) Transgenic OVA-specific CD4＋ T cells were 
co-cultured for 3 days with non-stimulated DCs, OVA323-339-pulsed 
DCs, OVA323-339-pulsed MAB1843-DCs, or OVA323-339-pulsed LPS- 
treated DCs. The CD4＋ T cell expression of IFN- and IL-4 was 
detected by intracellular staining and flow cytometry. The results are 
representative of three independent experiments.
amounts of MAB1843 are not cytotoxic to DCs. Next, to test 
the physiological effect of MAB1843 on DC maturation, we 
analyzed the expression of surface molecules and the 
secretion of cytokines in MAB1843- or LPS-induced (positive 
control) DCs. MAB1843 enhanced the expression of surface 
molecules such as CD80, CD86, and MHC class I and II (Fig. 
2A), and promoted the secretion of proinflammatory cytokines 
such as TNF-, IL-1, and IL-6 (Fig. 2B), but His-tagged protein 
itself did not affect to the production of cytokines in DCs 
(Supplementary Fig. 1). Whereas LPS stimulated the production 
of both IL-12p70 (involved in Th1 polarization) and IL-10 
(involved in Th2 polarization), MAB1843 specifically induced 
the secretion of IL-12p70 only (Fig. 2C), indicating that it may 
promote Th1 polarization. Furthermore, MAB1843 suppressed 
the capacity of dextran and LPS to induce endocytosis in DCs, 
indicating that it can functionally provoke the maturation of 
DCs towards promoting Th1 polarization.
MAB1843 Induces DC Maturation via TLR4 Signaling
Toll-like receptors of immune cells, such as macrophages and 
DCs, act as initiators of innate immunity by recognizing 
various pathogen-associated molecular patterns (PAMPs) (23, 
24). Apart from PAMPs, other M. abscessus antigens can 
activate DC maturation through TLR2 or TLR4 (7, 8). Thus, we 
tested whether MAB1843 can modulate DC maturation 
through TLRs as well. We analyzed the secretion of pro-
inflammatory cytokines, such as TNF- and IL-6, in wild type 
(WT), TLR2 knockout (KO), and TLR4 KO DCs treated with 
MAB1843, LPS (TLR4 agonist), Pam3CSK4 (TLR1/2 agonist), 
imiquimod (TLR7 agonist), ODN1826 (TLR9 agonist), or Poly 
I:C (TLR3 agonist). Whereas the secretion of TNF- and IL-6 
was observed in all three cell types stimulated by imiquimod, 
ODN1826, or Poly I:C, both cytokines were completely 
inhibited in Pam3CSK4-stimulated TLR2 KO DCs and in 
LPS-stimulated TLR4 KO DCs. The secretion of cytokines was 
completely blocked only in TLR4 KO DCs stimulated by 
MAB1843 or LPS (Fig. 3A), indicating that MAB1843 can 
modulate DC maturation through TLR4. As mitogen-activated 
protein kinases (MAPKs) and nuclear factor-kappa B (NF-B) 
signaling are reportedly downstream mediators in TLR4 
signaling (24), we investigated whether MAB1843 could 
enhance the activation of these two mediators. We measured 
the phosphorylation of MAPKs and the expression of NF-B 
inhibitor-alpha (IB) as an upstream molecule of NF-B in the 
cytosol. MAB1843 promoted the activation of MAPKs and 
NF-B in DCs derived from WT and TLR2-knockout mouse but 
not TLR4-knockout mouse (Fig. 3B and Supplementary Fig. 2). 
In addition, to investigate MAB1843 how to activate TLR4 
signaling, we measured the interaction between TLR4 and 
MAB1843 using the BLitz system (Supplementary Fig. 3). 
These results indicate that MAB1843 could induce the DC 
activation occurs through the activation of TLR4-mediated 
MAPKs and NF-B signaling by direct binding with TLR4. 
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MAB1843 enhances CD4＋ and CD8＋ T cell proliferation 
through DC maturation
Activated DCs mature during their migration to the lymph nodes. 
Once mature, they present antigens to naïve T cells and induce T 
cell proliferation (12). To characterize the effect of MAB1843 on 
DC and T cell interactions, we conducted a syngeneic mixed 
lymphocyte reaction assay using OT-I T cell receptor (TCR) 
transgenic CD8＋ T cells and OT-II TCR transgenic CD4＋ T cells 
(25). The carboxyfluorescein succinimidyl ester (CFSE)-conjugated 
ovalbumin (OVA)-specific CD8＋ and CD4＋ T cells were divided 
and co-cultured with DCs presenting OVA257-264 (Fig. 4A) or 
OVA323-339 (Fig. 4B), which were effectively activated by 
MAB1843 treatment and LPS stimulation. In addition, MAB1843 
also potentiated the production of IFN- by the activated CD4＋ T 
cells, but not that of IL-4 (Fig. 4C). Considering these results and 
the fact that MAB1843 stimulated the DC production of 
IL-12p70 (Fig. 1C), we propose that this effect could be used in 
immunotherapy to polarize naïve CD4＋ and CD8＋ T cells 
towards an IFN--producing Th1 phenotype. 
DISCUSSION
Several strains of non-tuberculous mycobacteria, such as 
Mycobacterium xenopi and Mycobacterium kansasii, have 
been known to cause pulmonary diseases (26, 27). Recent 
research has shown that M. abscessus induces an immune 
response through TLR2 and dectin-1 on host cells (7, 9), and 
MAB2560, the first purified antigen isolated from M. 
abscessus, activates DCs via TLR4 (8). It is essential to 
understand the relationship between M. abscessus and the 
immune system to develop a treatment strategy against 
infection by this species. Therefore, it was necessary to 
complete the research on how the immune system responds to 
M. abscessus-derived proteins. In this study, we investigated 
the effect of MAB1843, another purified antigen isolated from 
M. abscessus, on the immune system.
Here, we report that MAB1843 plays a role as an adjuvant 
to induce the secretion of proinflammatory cytokines and Th1 
polarization via DC stimulation. Specifically, MAB1843 induced 
the maturation of DCs and the secretion of proinflammatory 
cytokines (viz., IL-12p70, IL-1, IL-6, and TNF-) via TLR4, 
both actions of which are important in T cell activation.
It has been reported that the MAPK and NF-B pathways, 
activated by TLR signaling, are involved in the maturation of 
DCs and the secretion of proinflammatory cytokines (28, 29). 
In line with these studies, we found that MAB1843 induced 
the activation of MAPKs and NF-B in DCs, which is important 
since DC maturation and proinflammatory cytokine production 
play a key role in T cell polarization. Therefore, it is possible 
that MAB1843 enhances the production of IL-12 in DCs 
through the activation of MAPKs and NF-B, which in turn 
elicits the differentiation of CD4＋ T cells into Th1 cells, which 
produce IFN-. In line with these suggestions, we found that 
MAB1843 does indeed elicit Th1 polarization and IFN- 
production in Th1 cells. In this way, MAB1843 might be the 
link between the innate immune response by DCs and the 
adaptive immune response by Th1 cells to bacterial infection.
Our findings suggest that MAB1843 activates DCs and 
generates a Th1 response, as well as induces Th1 polarization 
by enhancing IL-12 production in DCs and boosting IFN- 
production in T cells. However, further in vivo studies are 
necessary to completely verify the immune response to M. 
abscessus.
In conclusion, MAB1843 is a potent protein that induces DC 
maturation and Th1-mediated immune response. Knowledge 
on the mechanism of how MAB1843 modulates the activity of 
DCs could contribute to the development of vaccines against 
M. abscessus. The identification of mycobacterial antigens that 
could be used as adjuvants to induce the activation of APCs 
may direct the development of immunotherapy in the future.
MATERIALS AND METHODS
Animals
Female 4-6-week-old C57BL/6 (H-2Kb and I-Ab) mice were 
purchased from Orient Bio (Daejeon, South Korea). TLR2 and 
TLR4 KO mice, as well as transgenic OT-I and OT-II mice, 
were purchased from Jackson Laboratory (Bar Harbor, ME, 
USA). All of the animals were housed in a specific pathogen- 
free facility and treated in accordance with the animal care 
guidelines (Institutional Animal Care and Use Committee 
(IACUC) number: KU14046).
Reagents and antibodies
Recombinant mouse granulocyte macrophage colony 
stimulating factor (rmGM-CSF) was purchased from BioLegend 
(San Diego, CA, USA). The Annexin V/PI apoptosis detection 
kit was purchased from BD Biosciences (East Rutherford, NJ, 
USA). Fluorescein isothiocyanate (FITC)- or phycoerythrin 
(PE)-conjugated Abs—namely, FITC anti-mouse CD11c Abs 
(Clone: N418), PE anti-mouse CD80 Abs (Clone: 16-10A1), PE 
anti-mouse CD86 Abs (Clone: GL-1), PE anti-mouse H-2Kd/ 
H-2Dd Abs (Clone: 34-1-2S), PE anti-mouse I-A/I-E Abs (Clone: 
M5/114.15.2), FITC anti-mouse IFN- Abs (Clone: XMG1.2), 
and PE anti-mouse IL-4 Abs (Clone: BVD4-1D11)—were 
purchased from BioLegend. TNF-, IL-1, IL-6, IL-10, and 
IL-12p70 ELISA kits were purchased from eBioscience (San 
Diego, CA, USA). FITC-conjugated dextran was purchased 
from Sigma-Aldrich (St. Louis, MO, USA). The TLR agonists 
(viz., LPS from Escherichia coli O111:B4, Pam3CSK4, 
imiquimod, Poly I:C, and ODN1826) were purchased from 
Invivogen (San Diego, CA, USA). Antibodies against phospho- 
ERK, phospho-p38, phospho-JNK, IB, and -actin were 
purchased from Santa Cruz Biotechnology (Santa Cruz, CA, 
USA). CFSE was purchased from Life Technologies (Eugene, 
OR, USA).
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Cloning of the MAB1843 gene
The MAB1843 gene was isolated from the full genome of M. 
abscessus for cloning into the E. coli BL21 strain. MAB1843 
was amplified using a forward primer (5'-CATATGATGAA 
GCGTCTGATCCTCGGT-3') and a reverse primer (5'-AAGC 
TTGTTGACGGGCGCGTTCAGGAA-3'). Thereafter, the PCR 
products were cleaved by NdeI and HindIII, and the cleaved 
genes were then inserted into the pET-22b(＋) vector (Novagen, 
Madison, WI, USA).
Purification of MAB1843 from E. coli BL21
The transformed E. coli BL21 was incubated in Luria-Bertani 
broth containing 100 g/ml of ampicillin. When the optical 
density at 600 nm reached 0.4-0.6, 1 mM of isopropylthio-- 
D-galactoside was added to the E. coli BL21 culture medium, 
which was then incubated for 6 h. The E. coli BL21 cells were 
then harvested and lysed using lysozyme, dithiothreitol, 
phenylmethanesulfonyl fluoride (PMSF), and DNase I. The 
supernatant was analyzed by affinity chromatography with 
Ni-NTA agarose resin. The eluted solution was concentrated 
and dialyzed against phosphate-buffered saline (PBS). Finally, 
endotoxins were removed by polymyxin B-agarose (Sigma- 
Aldrich), and the endotoxin level was measured using the LAL 
test kit (Lonza).
Generation of murine bone marrow dendritic cells
DCs were collected from the bone marrow of the tibia and 
femora of C57BL/6 mice. The progenitor cells were isolated 
from the bone marrow, and red blood cell lysis buffer was 
added (Sigma-Aldrich). These cells were then mixed with 
RPMI 1640 medium containing 10% fetal bovine serum, 1% 
penicillin/streptomycin, and GM-CSF. The cells were seeded 
into 12-well cell culture plates and incubated at 37oC in a 5% 
CO2 atmosphere. Fresh medium was added on the third day. 
On the sixth day, the cells were further treated or harvested.
Western blot analysis
The harvested cells were washed with PBS and lysed using a 
lysis buffer (containing 0.5% NP-40, 1 mM EDTA, 50 mM 
Tris-HCl (pH 8.0), 120 mM NaCl, 0.5 mM PMSF, 0.5 M NaF, 
and 0.01% protease inhibitor cocktail (Biobasic, Amherst, NY, 
USA)). SDS-PAGE was conducted using a 10% polyacrylamide 
gel, following which the protein bands were transferred to a 
polyvinylidene difluoride membrane. After blocking the 
membrane with 5% skimmed milk, primary Abs (anti-p-p38, 
anti-p-ERK, anti-p-JNK, anti-IB, and anti--actin) were added 
to the membrane and incubation was carried out overnight at 
4oC. On the next day, after rinsing with Tris-buffered saline 
and Tween 20, the anti-mouse and anti-rabbit secondary Abs 
were added to the membrane and a further incubation for 1 h 
at room temperature (RT) was carried out. After rinsing the 
membrane, enhanced chemiluminescence solution was added, 
and target bands were identified using the LAS-4000 imaging 
system (Fuji Film, Tokyo, Japan). To enable interaction with 
other antibodies, stripping buffer (Thermo Scientific, Waltham, 
MA, USA) was added to the membrane, following which the 
blocking step was repeated, and new antibodies were added.
Cytotoxicity analysis
MAB1843- or LPS-treated DCs were harvested and rinsed with 
PBS. Annexin V/PI staining was performed on these cells for 
15 min at RT. The cytotoxicity of MAB1843 on DCs was 
analyzed by flow cytometry using the FACS Calibur instrument 
(BD Biosciences).
Endocytosis ability analysis
MAB1843- and LPS-treated DCs were treated with FITC- 
conjugated dextran and incubated for 45 min at 37oC and 4oC, 
respectively. The DCs were then harvested and rinsed with 
PBS. Thereafter, the DCs were stained using the PE-conjugated 
anti-CD11c Ab and analyzed by flow cytometry.
Mixed Lymphocyte Reaction (MLR)
MAB1843- or LPS-treated DCs were incubated with OVA257-264 
or OVA323-339. Then, 1 × 104 DCs and 1 × 105 CFSE-labeled T 
cells were co-cultured in a 96-well cell culture plate. These 
transgenic OVA-specific CD8＋ and CD4＋ T cells were 
isolated from splenocytes of OT-I and OT-II mice, respectively. 
After 96 h, the cells were harvested and rinsed with PBS. Then, 
the cells were stained with Cy5 anti-CD8 or Cy5 anti-CD4 Abs 
and further analyzed by flow cytometry.
Intracellular staining
The harvested and rinsed cells were fixed in 4% parafor-
maldehyde and then permeabilized using saponin buffer. The 
cells were stained with anti-IFN- and anti-IL-4 Abs for 20 min. 
Enzyme-Linked immunosorbent assay 
The levels of IL-12p70, IL-10, IL-1, TNF-, IL-6, and IFN-  were 
measured by ELISA (eBioscience; R&D Systems, Minneapolis, 
MN, USA).
Blitz assay
The direct binding between rmTLR4/MD2 and MAB1843 was 
performed using the BLItz system (ForteBio, Menlo Park, CA). 
Human rTLR4/MD2 tagged with anti-penta-His (HIS) was 
purchased from R&D Systems (Minneapolis, MN). HIS 
biosensors (catalog no. 18-5078, Fortebio) were hydrated for 10 
min prior to the experiment. The concentration of HIS-tagged 
rmTLR4/MD2 was 0.1 mg/ml, and that of purified MAB1843 was 
0.1, 0.5, and 1 mg/ml and BSA was 1 mg/ml. The setting was as 
follows: initial baseline for 30 s, loading for 300 s, baseline for 
60 s, association for 120 s, and dissociation for 120 s. 
Statistical analysis
All experiments were repeated at least three times, with 
consistent results. Unless otherwise stated, data are expressed as 
the mean ± SEM. Variance analysis was used to compare 
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experimental groups with control values, whereas comparisons 
between multiple groups were made using Tukey’s multiple 
comparison tests (Prism 3.0; GraphPad software). A P value of 
less than 0.05 was considered to indicate statistical significance.
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